Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Adaptive Biotechnologies Corp (ADPT) vs AES Corp (AES) Price & Performance

Adaptive Biotechnologies CorpTrade

Price performance (Past 24H)

Key statistics

Adaptive Biotechnologies Corp vs AES Corp — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while AES Corp trades at $14.7 (market cap $10.49B). The key difference: AES Corp is far larger — about 2.6× Adaptive Biotechnologies Corp's market cap, and AES Corp pays a 4.79% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.

ADPTAES
Market Cap
$4.04B$10.49B
Sector
HealthUtilities
52-Week High
$25.45$17.28
52-Week Low
$12.30$12.51
Enterprise Value
$4.10B$40.75B
Dividend Yield
4.79%

Returns comparison

Trailing returns across standard periods

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Read more on ADPT

About AES Corp

AES is a global power company operating across 14 countries and 4 continents. Its current generation portfolio as of year-end 2021 consists of over 31 gigawatts of generation, with the generation mix composed of renewables (43%), gas (32%), coal (23%), and oil (2%). The company has 3.5 gigawatts of generation under construction. AES has majority ownership and operates six electric utilities distributing power to 2.6 million customers.

Read more on AES